Improved synthesis of a DNA-dependent protein kinase inhibitor IC86621

Arch Pharm Res. 2012 Mar;35(4):639-45. doi: 10.1007/s12272-012-0407-1. Epub 2012 May 3.

Abstract

An improved synthesis of DNA-dependent protein kinase inhibitor, IC86621 is described. This developed method provides an easy access to this simple molecule by using amination, acetylation and Fries rearrangement reactions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetophenones / chemical synthesis*
  • Acetophenones / chemistry
  • Acetophenones / pharmacology
  • Amination
  • Chemistry Techniques, Synthetic / methods
  • DNA-Activated Protein Kinase / antagonists & inhibitors*
  • Drug Design*
  • Molecular Structure
  • Morpholines / chemical synthesis*
  • Morpholines / chemistry
  • Morpholines / pharmacology
  • Phenols / chemistry
  • Protein Kinase Inhibitors / chemical synthesis*
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / pharmacology

Substances

  • 1-(2-hydroxy-4-morpholin-4-ylphenyl)ethanone
  • Acetophenones
  • Morpholines
  • Phenols
  • Protein Kinase Inhibitors
  • DNA-Activated Protein Kinase
  • 3-bromophenol